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Background: Group-based psychosocial therapy, such as group Cognitive Stimulation Therapy, 
improves cognition and quality of life in people living with dementia. Neuropsychiatric symptoms 
and restricted mobility are common complications for people with Parkinson’s-related dementia 
(PRD) and may limit access to, and participation in, group activities. This study describes the 
development of a condition-specific, home-based psychosocial therapy for people with PRD 
ready to be trialled in a clinical population.
Methods: By means of a multistage process, a draft therapy manual was developed in an 
iterative manner through collaboration with medical experts, researchers and Patient and Public 
Involvement (PPI) representatives. In stage 1, an extensive literature search of psychosocial 
therapies for dementia with potential relevance for Parkinson’s disease (PD) was undertaken to 
select a candidate therapy for adaptation. In stage 2, qualitative feedback from stakeholders and 
intelligence regarding existing nonpharmacological therapies for cognitive impairment in PD 
was combined to produce a prototype therapy manual. In stage 3, the manual was field tested 
in: 1) a home-setting using a 25-item assessment tool; and 2) at a local PD support group with 
PPI representatives. Based on the feedback from this phase, final design modifications were 
implemented and a draft therapy manual produced.
Results: The manual was developed in an iterative manner. Interview and focus group tran-
scripts identified three enduring themes: manual form and content, therapy acceptability by 
people with PRD, and companion guidance and support. Major adaptations included: removal 
of discrete levels of task complexity, removal of images that were potentially hallucinogenic 
or lacked clarity, and updating of the content.
Conclusion: We have successfully developed a Cognitive Stimulation Therapy-based psy-
chosocial therapy specifically adapted for people with PRD. The therapy is ready to trial in a 
pilot randomized controlled study.
Keywords: Parkinson’s disease, cognitive stimulation, MRC framework, intervention 
development
Introduction
England’s National Institute for Health and Clinical Excellence guidelines1 recommend 
that people with dementia have timely access to a psychosocial therapy, such as group 
Cognitive Stimulation Therapy (CST). Therapies such as CST may be appropriate 
for the less common types of dementia; however, they often do not meet the more 
complex needs (ie, restricted mobility, development of an inferiority complex within 
a group and neuropsychiatric symptoms) of people with dementia in the context of 
movement disorders.
Individuals with Parkinson’s disease (PD) can experience a wide range of motor and 
non-motor symptoms that present challenges in undertaking day-to-day activities.2–4 
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Approximately 30% of people with early, unmedicated PD 
report problems with attention and memory.5 A quarter of 
people with PD will develop mild cognitive impairment 
(PD-MCI) and are at increased risk of developing dementia.6 
The likelihood is that over 80% of people with PD will 
develop dementia after 20 years.7 People who have dementia 
with Lewy bodies (DLB) present with similar cognitive and 
motor symptoms to those with PD and dementia (PDD)8 and 
face similar challenges in accessing currently available psy-
chosocial treatment. Thus, there is a clinical need to develop 
and evaluate psychosocial support interventions for people 
with Parkinson’s-related dementia (PRD).
The Medical Research Council (MRC) guidelines for 
developing and evaluating complex interventions9 recom-
mend that complex interventions are developed systemati-
cally using the best available evidence and supported by an 
appropriate theoretical framework. Despite these guidelines, 
early findings from an ongoing Cochrane review of trials of 
cognitive training (a technique focusing on the repetition of 
cognitive exercises that may strengthen impaired cognitive 
processes) for people with PD and cognitive impairment 
suggests that relatively few studies meet these criteria.10 
The guidelines also recommend that interventions be devel-
oped to the point where they can reasonably be expected to 
have a worthwhile effect. One approach to following these 
guidelines is to modify an intervention that already has a 
robust theoretical, empirical and clinical rationale and an 
emerging evidence base of efficacy. The added benefit of this 
approach is that the development time can be reduced and the 
intervention is more likely to be scalable and sustainable.
This paper describes the methods and outcomes relating 
to the adaptation of a psychosocial therapy for people with 
PRD and their companions. To meet the needs and chal-
lenges of this specific clinical population, we adopted a user-
driven development framework including principles such 
as: active user involvement, iterative design, prototyping, 
evaluations with real users and usability considerations 
(Figure 1).11 Given the increased levels of caregiver burden 
in this population, the acceptability and tolerability of the 
therapy by companions (historically referred to as carers or 
caregivers) was also carefully considered. The effectiveness 
of the adapted therapy will be subsequently examined in an 
innovative feasibility and efficacy trial following the MRC’s 
clinical guidelines.9
Aims and objectives
The aim of this study was to develop a comprehensive 
psychosocial therapy specifically adapted for people with 
PRD and their companions. In this context, people with 
PRD comprise those who have PDD, PD-MCI or DLB. The 
specific objectives were:
•	 To conduct an extensive literature search to: 1) sum-
marize and review the existing evidence of psychosocial 
therapies for cognitive impairment and dementia related 
to PD; 2) develop a theoretical understanding of the likely 
processes of change; and 3) select a candidate therapy 
for adaptation (stage 1; summarize and review).
•	 Identify aspects of the candidate therapy that need to 
be adapted for people with PRD: Combine feedback 
from consultations with Patient and Public Involvement 
(PPI) representatives, clinical experts and intelligence 
regarding existing nonpharmacological therapies for 
cognitive impairment in PD to identify an initial set of 
adaptations required to produce the prototype therapy 
manual prior to field testing (stage 2; design).
•	 Evaluate the design against stakeholder requirements: 
Field test the prototype therapy manual to: 1) obtain 
feedback on the usability of the adapted therapy delivered 
by a companion in a home-setting and 2) obtain feedback 
from PPI representatives and clinical experts (stage 3; test 
and refine).
Stage 1 – summarize and review 
(existing research)
To summarize and review the existing evidence of psy-
chosocial therapies for cognitive impairment and dementia 
related to PD, we conducted a scoping exercise followed by 
a systematic review of seven studies (the number of studies 
reviewed is an indication of the paucity of high-quality 
research in this area). Scoping exercises do not evaluate the 
quality of the evidence reviewed; however, they can provide 
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Figure 1 The user-driven development framework adopted during the development 
of CsT adapted for people with Parkinson’s-related dementias (CsT-PD).
Abbreviations: CsT, Cognitive stimulation Therapy; iCsT, individual Cognitive 
stimulation Therapy; MCsT, Maintenance Cognitive stimulation Therapy; PD, 
Parkinson’s disease; rCT, randomized controlled trial.
 
Cl
in
ica
l I
nt
er
ve
nt
io
ns
 in
 A
gi
ng
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
16
0.
9.
19
2.
12
0 
on
 0
4-
Ap
r-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Interventions in Aging 2017:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1781
Psychosocial therapy for PrD
a narrative integration of evidence when the research area 
is complex and has not been comprehensively reviewed 
before.12 We considered studies that recruited people with 
PRD and: 1) reported a comparison between a psychoso-
cial intervention (cognitive-related) and a control group; 
2) reported a comparison between pre- and posttest; and 
3) reported the experiences of people with dementia partici-
pating in a psychosocial intervention. To map rapidly the 
key concepts underpinning effective cognitive stimulation 
in this clinical population, we synthesized knowledge from 
an ongoing, larger systematic review study.10 Throughout 
the review process, stakeholders (clinicians and PPI repre-
sentatives) were consulted to provide insight on what the 
literature failed to highlight. The process was iterative, rather 
than linear, and involved cycling between early findings and 
new insights. The findings from the scoping and systematic 
review are now discussed.
Early psychosocial therapies for people with dementia, 
such as Reality Orientation13 and Reminiscence Therapy,14,15 
evolved in parallel with the aim of reducing disorientation 
and improving well-being. Reality Orientation involves the 
use of supporting aids to establish time, season, location and 
other current or basic personal information, but has been criti-
cized for being rigid and confrontational, with doubts being 
raised about the therapy’s capability for demonstrating any 
clinically significant improvement.16 Supported by the use of 
memory aids (photographs, books or objects), Reminiscence 
Therapy involves discussing past experiences and events, 
but has also been found to have considerable shortcomings. 
A recent randomized, controlled trial of Reminiscence 
Therapy with people with dementia demonstrated no clinical 
benefit compared to “treatment as usual”, and anxiety levels 
had increased in companions.17 Continued use of both of 
these early psychosocial therapies has been cautioned by the 
American Psychiatric Association.18
More recently, use of CST has gained momentum and is 
recommended by a large number of National Health Service 
trusts in the UK. The principle behind CST supports the 
engagement in cognitive and social activities to enhance cog-
nitive functioning and quality of life of people with dementia. 
The therapy was developed by systematically selecting the 
aspects of the early psychosocial therapies that were benefi-
cial and building on these techniques by incorporating the 
discussion of new ideas and thoughts into various cognitively 
stimulating activities and topics. A randomized, controlled 
trial of the CST demonstrated improvements in quality of 
life and cognitive functioning.19 Economic analysis showed 
CST was cost-effective20 and that the results for cognition 
compared favorably with trials of cholinesterase inhibitors for 
Alzheimer’s disease. Since these early studies, the evidence 
base supporting the use of CST to improve outcomes for 
people with dementia has continued to grow.19
Following research on the effects of group CST, recent 
research has reported significant effects (quality of life and 
cognition) for people attending maintenance CST sessions 
(a follow-on therapy after group CST)21,22 and, to a lesser 
extent, individual CST (iCST).19 iCST is delivered individu-
ally to a person with dementia by a friend or a family member. 
A recent randomized, controlled trial of iCST showed that 
iCST did not result in improved cognition or quality of life 
for the person living with dementia, however, participating 
in iCST did enhance the quality of the caregiving relation-
ship and caregivers’ quality of life.23,24 These findings are 
relevant here, as companions of people with PRD are reported 
to experience burden and a lower quality of life due to the 
responsibility of supporting the complex physical and cog-
nitive needs of people with PRD.25 We are aware of only 
one exploratory study26 that has assessed the effectiveness 
of home-based CST in people with PRD using neuropsy-
chological assessment and molecular analysis. The authors 
reported that scores on the Montreal Cognitive Assessment,27 
Parkinson’s Disease Questionnaire-3928 and Quality of Life – 
Alzheimer’s Disease29 significantly improved following a 
7-week period of CST delivered by a family member. 
In addition, levels of serum brain-derived neurotrophic factor 
(BDNF; a neuroprotectant that colocalizes with dopaminer-
gic neurons) significantly improved at posttest. The sample 
size in this study was small and there was no control group; 
however, the ability to demonstrate positive change in a 
highly objective biomarker is encouraging.
Given the benefits offered by CST, maintenance CST, 
iCST and a recent Cochrane Review recommending sys-
tematic evaluation of different modalities of CST, including 
real-life settings,16 the home-based companion-delivered 
iCST was selected as the candidate therapy for adaptation. 
The modified version is henceforth referred to as CST-PD.
Process of change
In accordance with MRC guidance for developing and 
evaluating complex interventions,9 a good theoretical under-
standing of how the intervention effects change is required 
in order to identify and strengthen areas of weakness within 
the intervention.30 Prior to the design and prototyping stage, 
a literature scoping exercise was performed to identify the 
potential processes of change. At a fundamental level, for the 
people with PRD, the therapy may result in neurobiologic or 
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psychosocial changes or a combination of the two. Recent 
evidence supports the idea that nonpharmacologic therapies 
exert action on neurobiologic processes within the brain.26,31,32 
For example, Angelucci et al31 demonstrated that cogni-
tive training elevates BDNF in individuals with PD. The 
mechanism by which BDNF improves cognition is not yet 
fully understood, nor is it likely to be the sole mechanism 
responsible for clinically significant change, but only one 
of the components of which we are currently aware. While 
cognitive stimulation differs from cognitive training, the 
former therapy involving discussion and activities as opposed 
to guided practice on a standard set of cognitive tasks,33 an 
association between cognitive stimulation and serum BDNF 
has also been reported.26 The latter study is of particular 
relevance to the current research as the CST was delivered by 
family members in the home environment. Collectively, these 
studies suggest that if cognitive stimulation has the potential 
to elevate BDNF, the growth factor could be considered for 
use as a biomarker in future large-scale clinical trials of CST 
and adapted versions.
In addition to neurobiological variables, it is important to 
consider psychological and social factors. Social stigma or 
other socially imposed barriers can be a significant source of 
distress and thus impact on outcome.34 Examples of psycho-
social issues include negative social interactions, unemploy-
ment or early retirement due to symptoms, physical disability 
that prevents access to certain environments and changes to 
family life, such as increased dependency on a companion 
or partner.34–37 Negative psychosocial factors can lead to a 
decrease in personal efficacy, psychological well-being, and 
relationship satisfaction and increased social isolation and 
depression.35,36,38,39 CST-PD will seek to address the nega-
tive psychosocial outcomes of PDD, PD-MCI and DLB by 
providing opportunities for companion-supported mastery 
experiences; having the therapy delivered by a known and 
significant other may allow people with PRD to feel more 
comfortable challenging themselves in cognitively stimulat-
ing activities. Improvements in perceived personal efficacy, 
through mastery experiences, could foster interest and 
(re)engagement in social or previously enjoyed activities, 
lower vulnerability to depression and improve relationship 
satisfaction.40
It is also important to consider personal efficacy from 
the companions’ point of view: the change effected by the 
intervention may be influenced by the companions’ beliefs in 
their ability to deliver the therapy (instructional efficacy39). 
Companions’ level of perceived efficacy to motivate the 
people with PRD and promote mental stimulation may 
affect the therapy environment, the level of adherence, 
the quality of therapy delivered and, ultimately, outcomes 
for people with PRD (eg, cognition and quality of life). 
In school-based studies, instructors with high levels of 
instructional efficacy are reported to devote more time to 
learning, offer the appropriate level of help and praise and 
encourage autonomy.41 While CST-PD does not aim to create 
a school-based environment at home, there is potential for 
companions’ instructional efficacy to act as a change agent 
and influence therapy outcomes. Throughout the develop-
ment of CST-PD, companions will be consulted to identify 
their needs and to develop the necessary recourses to support 
instructional efficacy.
Stage 2 – design (modeling and 
piloting phases)
In the initial meeting with stakeholders (clinical experts, 
researchers and a PPI advisory group), user consultations 
took place to identify issues related to the nature of tasks and 
the therapy environment. Three key factors were identified: 
1) the potential impact of symptom-specific issues on the 
therapy, for example, physical limitations from motor impair-
ments, fluctuating levels of alertness and motor function, 
hallucinations and/or delusions, person-specific cognitive 
impairment, high levels of apathy and ability to promote 
self-management; 2) companions’ confidence in delivering 
CST-PD; and 3) whether physical activity-based tasks would 
be appropriate as part of the therapy. To fully address these 
issues, perspectives from professionals, companions and 
people with PRD were sought.
Methods
Participants
PD professionals (n=5), patient participants (n=3) and com-
panions (n=2) were recruited from neurology and geriatric 
psychiatry services in Greater Manchester. Patient par-
ticipants had a diagnosis of PD-MCI, PDD or DLB according 
to the appropriate consensus criteria for each condition.42–46
Procedure
The study received ethical approval from Yorkshire and 
the Humber–Bradford Leeds Research Ethics Committee 
(Reference: 15/YH/0024). All participants provided written 
informed consent or had a nominated consultee who provided 
the appropriate declaration. Focus groups were conducted by 
a CST-trained cognitive neuropsychologist and a psychology 
research assistant at the University of Manchester. PD profes-
sionals, companions (in this case, spouses) and people with 
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PRD were invited to attend separate focus groups. Based on 
the methods by Krueger and Casey47 and adapted for dementia 
by Bamford and Bruce,48 the groups were intentionally small, 
with no more than eight participants plus facilitators. As some 
companions and people with PRD were unable to attend the 
focus groups due to unforeseen medical or caring responsi-
bilities, a second focus group was held for companions and 
semi-structured interviews were conducted with a further 
companion and two people with PRD, in the home setting.
A semi-structured interview design probed opinions 
relating to a number of issues specific to people with PD 
and DLB, as well as those identified by our PPI advisory 
group, including the suitability of tasks to motor difficulties, 
psychiatric issues and cognitive difficulties. Digital voice 
recordings were made of all focus groups and interviews to 
enable transcription and analyses.
Focus groups
Professionals were split into two groups and asked to evalu-
ate six activities, spanning three topics, plus evaluate the 
introduction section of the original iCST manual. The groups 
were then asked to describe their evaluation to the other party, 
before having an open discussion of the points identified by 
the PPI advisory group. Finally, opinion was sought for five 
new topics, devised by the research team, before conclud-
ing the focus group with a yes/no topic inclusion/exclusion 
checklist to determine which subject areas were deemed most 
appropriate for the adapted therapy.
In the focus group for companions, participants were 
invited to try several of the activities, in pairs, over a range 
of different topic areas. Open discussion took place after each 
topic, with focus on the issues identified by the PPI advisory 
group. The focus group concluded with a yes/no topic inclu-
sion/exclusion checklist.
The focus group of people with PRD involved a short 
group CST session and preferences were observed from the 
conversations that resulted. This focus group also concluded 
with a yes/no topic inclusion/exclusion checklist.
Transcript analysis and reporting
To ensure an iterative development process, data analysis ran 
alongside data collection, that is, subsequent focus groups 
were adapted using information obtained from previous 
sessions. The process of analysis began with reading and 
re-reading each transcript. Salient comments were noted and 
grouped by commonality, within and across transcripts. Re-
reading, comparison and re-grouping of comments continued 
until the main themes and subthemes were identified. Data 
were reported in accordance with an abbreviated consoli-
dated criteria for reporting qualitative research (COREQ) 
structure.49
results
Three main themes were identified and are presented in 
Table 1 with subthemes and frequency of comments. The 
professionals provided comments on all but 3 of the 28 sub-
themes (89%). In contrast, companions and patients identified 
with a substantial proportion of the subthemes (64% and 61%, 
respectively), but tended to focus on specific issues that they 
considered most relevant to them.
To accurately represent the views of the participants, 
a single quote from each theme has been selected (agreed 
among authors), with five additional examples in Table 2.
Theme 1: manual form and content
All parties agreed that the content needed updating (eg, add 
topics on technology, computers, mobile phones) as well as 
making topics culturally inclusive. Professionals suggested 
that the topics should include: art, history, geography, pets, 
books, transport and sports (eg, golf and cycling), among 
others. People with PRD did not want to avoid sensitive top-
ics, but rather viewed CST-PD as an opportunity to facilitate 
discussion that otherwise would not usually happen:
[…] would it be possible for people like myself to have 
a general discussion on “do you miss work?”, “what ele-
ments of work do you miss?”. I can’t see it will work for 
all but maybe for some, you know […] I miss work so 
much, I miss the hassle, I miss the estimating, I miss the 
hiring, the firing, doing wages and all sorts. If I hadn’t 
got ill, I don’t think I would have ever retired. [Person 
with PRD]
In the iCST manual, each topic is split into two levels of 
difficulty; however, professionals highlighted that this format 
may be demotivating for those with deteriorating level of 
cognitive function. Professionals also felt that color-coded 
sections would be of benefit to ease the selection of topics 
based on one’s interest. There was consensus that lengthy 
paragraphs should be avoided and more images should be 
included to keep topics from becoming dry and cluttered. 
Companions also suggested the use of good-quality and 
thin paper, as thicker paper can cause problems with page 
turning in people with tremor. Professionals and companions 
also pointed out that any speech impairment might make 
reading aloud difficult, so any instructions to read aloud 
should be optional.
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Key recommendations
•	 Encourage opinion-based questions.
•	 Include more photography, limit paragraph length.
•	 Modernize and extend the topic content, make it 
multicultural.
•	 Remove the two discrete levels of complexity and gradu-
ally increase the complexity of the tasks within each topic.
•	 Color code topic sections.
•	 Include optional instructions to read information aloud.
Theme 2: therapy acceptability in PD
All parties expressed the desire for the CST-PD to improve 
cognition, and professionals suggested card games as a 
potential tool to help with strategy and memory. Compan-
ions felt that the inclusion of constructive activities might 
successfully distract people with PRD from the compulsive, 
repetitive and stereotyped behaviors known as punding. 
Companions and people with PRD expressed polarized 
views of apathy: companions were concerned about getting 
individuals started with the therapy, whereas people with 
PRD were more positive and felt that the therapy would be 
motivating, encouraging and would alleviate boredom:
I love things like this, I do. I enjoy it. It’s good fun as well 
and it gives you something to talk about. [Person with PRD]
Professionals and people with PRD commented on visual 
and perceptual issues and pointed out that in the original 
iCST manual, some images were too busy and confusing with 
many shapes and colors that may cause hallucinations. The 
professionals were keen for art topics to remain, but wanted 
art images to be less vivid, disturbing and chaotic. Profes-
sionals also thought that abstract questions relating to art 
(eg,“Do you think there is a message behind the painting?”) 
or superstition-based questions should be reconsidered and 
revised to avoid precipitating or perpetuating complications 
such as delusions.
Table 1 Summary of themes and subthemes identified from focus groups and interviews
Themes and subthemes Frequency of comments Total
Professionals Companions People with PRD
Manual form and content
Topic variety and development 8 4 21 33
Modernization 8 6 1 15
expanding on previous interests 2 7 1 10
Bringing the outside in 3 2 3 8
Difficulty 3 1 4 8
Cultural relevance 7 – – 7
Formatting 3 1 1 5
Quality 2 – 3 5
Therapy acceptability in PD
hallucinations and perceptual issues 16 – 2 18
Motor issues 12 4 – 16
general suitability – – 12 12
Cognition 1 3 4 8
eating (anosmia, swallowing, salivation, dexterity) 6 – – 6
Apathy – 4 2 6
location of therapy 1 2 1 4
Delusions 4 – – 4
Punding 1 3 – 4
Isolation 1 – 1 2
Speech difficulties 1 – – 1
Impulse control (finances) 1 – – 1
Anxiety – 1 – 1
Companion considerations
Improving written guidance for companions 7 3 1 11
Therapy acceptability for companions 2 6 1 9
Involving others 2 3 1 6
Avoid confrontation 1 2 2 5
Training 2 – 2 4
Failures and successes 2 1 – 3
Planning in advance 1 1 – 2
Abbreviations: PD, Parkinson’s disease; PrD, Parkinson’s-related dementia.
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With regards to motor impairment, all participants agreed 
that delivering CST-PD in the home was most acceptable, 
and might help reduce feelings of isolation or boredom. 
Professionals and some companions were concerned about 
the physical activity-based tasks in the existing therapy. 
Following a lengthy discussion, it was determined that 
without individual physiotherapist assessment, the potential 
risks of including physical exercise activities outweighed 
the potential gain, and therefore, it was recommended that 
dedicated physical exercise be excluded from the activities 
in CST-PD.
Key recommendations
•	 Include card/strategy games and constructive activities.
•	 Exclude physical activity tasks.
•	 Avoid disturbing images and abstract questions.
Theme 3: companion considerations
All parties were cautious when discussing the acceptability 
of the therapy for companions with a caregiving role. Profes-
sionals and companions acknowledged that dyads engaging 
in constructive discussion might be of benefit, but exhaustion 
and feelings of pressure of companions and family members 
could not be disregarded. Involving other family members 
(eg, grandchildren) was suggested in all focus groups. 
Participants felt that involving family members would be 
a pleasurable experience and would limit any burden that a 
dyadic therapy might introduce:
We are together all the time. Sometimes the relationship 
gets strained because you are at the end of it. So, I think 
my daughter could get my husband to do a lot more than 
I could. She could sit down with him and talk to him about 
things that he just says to me “Oh you are not listening”. 
So I think it is imperative to involve your immediate family. 
(Companion)
Companions communicated concerns about self-doubt 
and uncertainty in delivering the therapy, and all participants 
agreed advice should be provided on what to do in situations 
of confrontation. With respect to the current iCST manual, 
all participants felt that the introduction was too long and 
overly complicated, and suggested reducing it to a single 
Table 2 Additional examples of content within each major qualitative theme
Themes Example quote
Manual form and 
content
“I think it is not fit for today’s purposing. There is no mention of computers, mobile phones…” (companion)
“It’s important to make it multi-cultural but keep it British”; “(include) the world, the local, the personal” (professional)
“Focus on things that they once used to enjoy doing that they are not doing any longer. It is quite possible they could do it 
in a different way” (professional)
“And maybe color guide. You know how sometimes in books you have sections that are colored off and you can just turn 
to them”. [The person with PRD might say] “that pink section was good last time and we’ll go back to the pink section” 
(professional)
“It might be best not to include the difficulty levels cause you can almost see someone doing this again a year later and 
finding out they can’t use level B anymore, whereas they did last year and it kind of emphasises deterioration” (professional)
Therapy acceptability 
in PD
“It’s good to be able to discuss. I mean, you are reminding me of things and that’s encouraging me, that’s picking me up a 
bit” (person with PRD)
“Cause it helps you, to keep your memory and things. If you are using that part of your brain on a regular basis, I can see it 
being helpful” (person with PRD)
“It’s very easy to stay at home but sometimes you just wake up and you think oh, what am I going to do today and it’s that 
passing time… I want to do something that I am interested in and I think that’s something that holds us all” (person with 
PrD interview)
“I think if you have someone who is tremor dominant, I would be concerned about what happened if they failed (physical 
activity). So it’s about symptoms rather than activity… (It is) probably best not to have these things in” (professional)
“We were concerned about the hallucinogenic nature of the images. not very calming. We quite liked the idea of discussing 
paintings but you would have to be careful with the images. Quite a lot of these images can freak out Parkinson’s patients” 
(professional)
Companion 
considerations
“It depends on your relationship at that moment and whether you’ve had a good week or a bad week. And what pressures 
you’ve got as a carer… It is not always practical and sensible to sit down because things can get volatile” (companion)
“You’ve got to have absolute patience… It’s very difficult to understand just how miserable a person can be in the wrong 
hands” (person with PRD interview)
“I am not saying I could keep it going for twenty minutes necessarily” (companion)
“Don’t forget, if people are carers and perhaps not sleeping, they are just so, so tired. They won’t even get through a page 
of this (introduction) text” (professional)
“It surely got to be a shared effort between the therapist” (person with PRD interview)
Abbreviations: PD, Parkinson’s disease; PrD, Parkinson’s-related dementia.
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page with 10 key points including a summary of what is in 
the manual, what support there is and how to find it. The 
importance of appropriate training was of interest to profes-
sionals and people with PRD, with professionals suggesting 
that companions read through materials in advance of the 
therapy session.
Key recommendations
•	 Involve others (family members, grandchildren, friends).
•	 Streamline the introduction.
•	 Provide advice on managing challenging behavior.
•	 Include strategies to build instructional efficacy.
Stage 3: test and refine
At the end of the design stage, a final draft CST-PD therapy 
manual was produced. This was subsequently field tested by 
dyads ie, people with PRD and companions (Part A). The 
purpose was to evaluate the therapy manual (in context) 
against the user requirements defined in Stage 2. Additional 
opinion was also sought from PPI representatives at a local 
Parkinson’s UK branch meeting to better understand if the 
intervention and delivery processes could work in a real 
world (Part B).50
Part A (companions and people with PrD)
Methods
Participants
Companions (n=3) and people with PRD (n=3) participated 
in the field testing. Participants were recruited from local 
neurology and geriatric psychiatry services in Greater 
Manchester and had a diagnosis of either PD-MCI, PDD 
or DLB according to the appropriate consensus criteria for 
each condition.42–46
Procedure
The study received favorable ethical opinion from 
Yorkshire and the Humber–Bradford Leeds Research 
Ethics Committee (Reference: 15/YH/0531). Dyads com-
pleted a portion (2 weeks; ~6 sessions) of the program 
with support from the research team. At the end of the 
2-week period, dyads completed a usability assessment 
and provided detailed qualitative feedback. The usability 
assessment was based on the 10-item System Usability 
Scale,51,52 which was adapted to suit the needs of this study 
and population (ie, the term “system” was replaced with 
“therapy manual” and additional questions relating to 
formatting, layout and so on were included). The adapted 
assessment consisted of 24 statements (eg, “I found the 
manual unnecessarily complex” and “I would imagine 
that most companions would learn to use the manual 
very quickly”) to which the participants provided free 
answers. Items were categorized with relevance to themes 
from the focus groups and interviews, and are discussed 
accordingly.
results
Of the 24 items, 11 statements were grouped under Theme 1, 
“Manual form and content”, 9 under Theme 2, “Therapy 
acceptability in PD”, and 4 under Theme 3, “Companion 
considerations”.
Theme 1: manual form and content
All participants found the manual layout was consistent, the 
pages were easy to navigate, the topics were well-integrated 
with plenty of choice, and the size and color of the print 
was good. Participants reported they would appreciate 
additional materials consisting of games, adult coloring 
and stationary.
Theme 2: therapy acceptability in PD
All participants with PRD agreed that they would feel 
confident using the manual and would likely use it three times 
per week. The task complexity was perceived differently 
depending on the level of cognitive impairment; the partici-
pant with PD-MCI found the level of complexity appropriate, 
and the participant with PDD found the tasks challenging. 
The person with DLB found the manual, images and tasks 
challenging. The participant with DLB and their companion 
agreed that the manual was not suitable, with the companion 
attributing this to the advanced level of cognitive impairment 
of the participant.
Theme 3: companion considerations
Both participants with dementia, but not the participant with 
PD-MCI, were definitive that they would need support to 
use the manual. All companions agreed that they would be 
able to learn to use the manual quickly, although they felt it 
beneficial to have some preparation time before commencing 
use of the manual.
Key recommendations
•	 Companion-training package should include preparation 
time.
•	 Additional support may be required depending on the 
level of cognitive impairment.
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Part B (PPI representatives)
Methods
Participants
Thirty-three PPI representatives (companions and people 
with PRD) from a local Parkinson’s UK community group 
took part.
Procedure
PPI representatives piloted the therapy questions and topic 
guides in a single group session held at a Parkinson’s UK 
support group. Attendees were given the option of completing 
a feedback form to comment on the usability and accept-
ability of the therapy. Four topics were randomly selected 
from the manual for use on the day: herbs, newspapers, 
Blackpool and ball games. A modified version of the in-house 
usability assessment, using a five-point Likert response scale 
(1=	“strongly disagree” to 5=	“strongly agree”), with one 
question reverse-scored, was circulated to gather feedback.
This phase of the study was carried out as a PPI session 
and, as such, ethical approval was not obtained to record 
opinion from the PD UK community group. Feedback was 
gathered anonymously and no further information (identifi-
able or otherwise) was collected about the volunteers.
results
Sixteen volunteers elected to complete the feedback form. 
Responders strongly agreed that it was easy to engage in 
the session (median =5), to stimulate conversation using 
the topic materials (median =5), and that the discussion was 
stimulating and interesting (median =5). Responders also 
agreed that the session content (median =4.5) and images 
(median =4) were clear and easy to understand, that there 
was opportunity to personalize the session (median =4) and 
that they would like to do a similar activity in the future 
(median =4). Volunteers were uncertain about whether the 
level of complexity was suitable for someone with memory 
problems (median =3, “neither agree nor disagree”).
Key recommendation
In future evaluations, assess topic acceptability in people 
with moderate–severe cognitive impairment.
Discussion
This research adapted and tested a psychosocial therapy for 
people with PRD and their companions. A user-centered 
design was employed, and professionals, people with 
PRD, companions and researchers worked collaboratively 
to modify an existing therapy to meet specific user needs. 
The first step was to identify and review the evidence base for 
psychosocial therapies for people with PRD and the potential 
mechanisms of change. Subsequently, a candidate therapy 
for adaptation was selected. A basic prototype manual (loose 
pages and sample topic ideas) was developed early in the 
second phase to allow the proposed therapy to be discussed in 
a more meaningful way with stakeholders. The final version 
of the therapy manual was developed iteratively through a 
series of focus groups, interviews, a group demonstration 
and field testing.
An advantage of co-developing the intervention with 
stakeholders is that it limits the risk of missing critical thera-
peutic requirements and provides a positive and satisfying 
experience for the individuals involved (ie, the therapy meets 
the goals of its users because its users have been actively 
involved in the iterative development of the therapy). This 
aspect was particularly important for CST-PD, as the target 
population is frail, the symptoms complex and a therapy 
companion is required. As the specific needs of this popula-
tion are not well understood, the design of the therapy could 
not be informed through literature only. Hence, we involved 
people with PRD, companions and health professionals as 
partners throughout the design process. Testament to CST-PD 
meeting the needs of people with PRD and their compan-
ions is the positive feedback received from the Parkinson’s 
UK field testing session. The comments indicated that the 
members engaged with the session and enjoyed the activities. 
Although speculative at this stage, these findings suggest 
the therapy might address the neuropsychiatric symptoms 
(eg, apathy and anxiety) associated with increased caregiver 
distress in PRD.50 The successful delivery of the session in 
a group format also highlights the versatility of the adapted 
therapy and indicates that it may be appropriate for people 
with PRD attending group-based sessions.
This study has some limitations. The number of par-
ticipants is small, and focus group methodology proved 
challenging for this companion and patient population, given 
their complex and changeable needs. The obstacles faced in 
bringing participants together for a focus group demonstrate 
how difficult it might be for companions and people with 
PRD to attend group CST sessions, and reinforce the appro-
priateness of developing a home-based therapy that can be 
carried out at the convenience of the people involved.
Conclusion
There is an urgent need to expand the management options 
for people with PRD beyond standard pharmacologic 
approaches. Psychosocial therapies suitable for this group 
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of people may, therefore, have a vital role. The development 
phase of CST-PD was extensive and involved an iterative 
process comprising theory-driven recommendations, evalu-
ation of users’ needs, prototype manual development and 
field testing. This aspect of the trial resulted in the produc-
tion of CST-PD, a therapy manual specifically tailored for 
people with PRD and their companions. Following the MRC 
guidelines,9 a pilot randomized clinical trial is currently 
underway to examine the feasibility, acceptability and toler-
ability of CST-PD and to explore the outcome measures.53 
The pilot data will be used to inform a subsequent, definitive, 
multisite randomized controlled trial.
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